Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

被引:110
作者
Erdmann, J
Raible, J
Maki-Abadi, J
Hummel, M
Hammann, J
Wollnik, B
Frantz, E
Fleck, E
Hetzer, R
Regitz-Zagrosek, V
机构
[1] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Deutesch Herzzentrum, Berlin, Germany
[4] Univ Istanbul, Inst Child Hlth, Dept Med Genet, Istanbul, Turkey
关键词
D O I
10.1016/S0735-1097(01)01387-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent. Background Mutations in the MYBPC3 gene represent the cause of HCM in similar to 15% of familial cases. MYBPC3 mutations were reported to include mainly nonsense versus missense mutations and to be characterized by a delayed onset and benign clinical course of the disease in Japanese and French families. We investigated the features that characterize MYBPC3 variants in a large, unrelated cohort of consecutive patients. Methods The MYBPC3 gene was screened by single-strand conformational polymorphism analysis and sequencing. The clinical phenotypes were analyzed using rest and 24-h electrocardiography, electrophysiology, two-dimensional and Doppler echocardiography and angiography. Results We identified 13 mutations in the: MYBPC3 gene: one nonsense, four missense and three splicing mutations and five small deletions and insertions. Of these, 11 were novel, and two were probably founder mutations. Patients with MYBPC3 mutations presented a broad range of phenotypes. In general the 16 carriers of protein truncations had a tendency toward earlier disease manifestations (33 +/- 13 vs. 48 +/-9 years; p = 0.06) and more frequently needed invasive procedures (septal ablation or cardioverter-defibrillator implantation) compared with the 9 carriers of missense mutations or in-frame deletions (12/16 vs. 1/9 patients; p < 0.01). Conclusions Multiple mutations, which include missense, nonsense and splicing mutations, as well as small deletions and insertions, occur in the MYBPC3 gene. Protein truncation mutations seem to cause a more severe disease phenotype than missense mutations or in-frame deletions. (J Am Coll Cardiol 2001;38:322-30) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
  • [1] PROGNOSTIC IMPLICATIONS OF NOVEL BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE-MUTATIONS THAT CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    ANAN, R
    GREVE, G
    THIERFELDER, L
    WATKINS, H
    MCKENNA, WJ
    SOLOMON, S
    VECCHIO, C
    SHONO, H
    NAKAO, S
    TANAKA, H
    MARES, A
    TOWBIN, JA
    SPIRITO, P
    ROBERTS, R
    SEIDMAN, JG
    SEIDMAN, CE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 280 - 285
  • [2] CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    BONNE, G
    CARRIER, L
    BERCOVICI, J
    CRUAUD, C
    RICHARD, P
    HAINQUE, B
    GAUTEL, M
    LABEIT, S
    JAMES, M
    BECKMANN, J
    WEISSENBACH, J
    VOSBERG, HP
    FISZMAN, M
    KOMAJDA, M
    SCHWARTZ, K
    [J]. NATURE GENETICS, 1995, 11 (04) : 438 - 440
  • [3] Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy
    Carrier, L
    Bonne, G
    Bahrend, E
    Yu, B
    Richard, P
    Niel, F
    Hainque, B
    Cruaud, C
    Gary, F
    Labeit, S
    Bouhour, JB
    Dubourg, O
    Desnos, M
    Hagege, AA
    Trent, RJ
    Komajda, M
    Fiszman, M
    Schwartz, K
    [J]. CIRCULATION RESEARCH, 1997, 80 (03) : 427 - 434
  • [4] Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene
    Charron, P
    Dubourg, O
    Desnos, M
    Bennaceur, M
    Carrier, L
    Camproux, AC
    Isnard, R
    Hagege, A
    Langlard, JM
    Bonne, G
    Richard, P
    Hainque, B
    Bouhour, JB
    Schwartz, K
    Komajda, M
    [J]. CIRCULATION, 1998, 97 (22) : 2230 - 2236
  • [5] TRUNCATED ERYTHROPOIETIN RECEPTOR CAUSES DOMINANTLY INHERITED BENIGN HUMAN ERYTHROCYTOSIS
    DELACHAPELLE, A
    TRASKELIN, AL
    JUVONEN, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) : 4495 - 4499
  • [6] Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
    Erdmann, J
    ShimronAbarbanell, D
    Rietschel, M
    Albus, M
    Maier, W
    Korner, J
    Bondy, B
    Chen, K
    Shih, JC
    Knapp, M
    Propping, P
    Nothen, MM
    [J]. HUMAN GENETICS, 1996, 97 (05) : 614 - 619
  • [7] A molecular map of the interactions between titin and myosin-binding protein C - Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy
    Freiburg, A
    Gautel, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (1-2): : 317 - 323
  • [8] Fung DC, 1999, HUM MUTAT, V14, P326, DOI 10.1002/(SICI)1098-1004(199910)14:4<326::AID-HUMU8>3.0.CO
  • [9] 2-F
  • [10] PHOSPHORYLATION SWITCHES SPECIFIC FOR THE CARDIAC ISOFORM OF MYOSIN BINDING PROTEIN-C - A MODULATOR OF CARDIAC CONTRACTION
    GAUTEL, M
    ZUFFARDI, O
    FREIBURG, A
    LABEIT, S
    [J]. EMBO JOURNAL, 1995, 14 (09) : 1952 - 1960